• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Combined transfacial and neurosurgical approach to malignant tumours of the ethmoid sinus.

作者信息

Salvan D, Julieron M, Marandas P, Janot F, Leridant A M, Domenge C, Mamelle G, Schwaab G, Luboinski B

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Institute Gustave Roussy, Villejuif, France.

出版信息

J Laryngol Otol. 1998 May;112(5):446-50. doi: 10.1017/s0022215100140745.

DOI:10.1017/s0022215100140745
PMID:9747472
Abstract

In order to understand the risks and benefits of a combined transfacial and neurosurgical procedure for neoplasms of the ethmoid sinus, we reviewed all patients who underwent this surgical approach in our department between 1986 and 1994. The study included 41 patients. Pathological diagnoses included adenocarcinoma (31 patients), squamous cell carcinoma (three patients), aesthesioneuroblastoma (three patients), other (four patients). The overall morbidity rate was 39 per cent, and the post-operative mortality rate was 2.5 per cent. Complications were statistically more likely in patients with bone skull base reconstruction. The main carcinologic failures were local recurrences (24 per cent) and metastases (22 per cent). The one-year, three-year and five-year Kaplan Meir survival rates were respectively 84 per cent, 53 per cent and 36 per cent. In conclusion, the mortality and morbidity were acceptable, especially when no bone skull base reconstruction was performed. Better local control justifies a combined procedure with post-operative radiotherapy when tumours involve or reach the skull base.

摘要

相似文献

1
Combined transfacial and neurosurgical approach to malignant tumours of the ethmoid sinus.
J Laryngol Otol. 1998 May;112(5):446-50. doi: 10.1017/s0022215100140745.
2
[Ethmoid adenocarcinoma: trans-facial approach for anterior skull base resection. a series of 80 cases].[筛窦腺癌:经面部入路切除前颅底。80例系列报道]
Ann Otolaryngol Chir Cervicofac. 2004 Sep;121(4):213-21. doi: 10.1016/s0003-438x(04)95511-9.
3
Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base.基于顺铂的新辅助化疗及联合切除术治疗累及和/或侵犯颅底的筛窦腺癌。
Arch Otolaryngol Head Neck Surg. 1996 Jul;122(7):765-8. doi: 10.1001/archotol.1996.01890190061014.
4
[Combined transfacial and neurosurgical approach for the treatment of ethmoid cancers].[经面部和神经外科联合入路治疗筛窦癌]
Ann Otolaryngol Chir Cervicofac. 2003 Feb;120(1):21-9.
5
Treatment results for ethmoid sinus carcinoma.筛窦癌的治疗结果。
J Laryngol Otol. 2009 Oct;123(10):1120-4. doi: 10.1017/S0022215109990752. Epub 2009 Aug 3.
6
[Combined ORL and neurosurgical approach in adenocarcinoma of the ethmoid. Preliminary results apropos of 15 cases].[筛窦腺癌的耳鼻喉科与神经外科联合手术入路。15例初步结果]
Ann Otolaryngol Chir Cervicofac. 1987;104(5):347-51.
7
[Combined approach to malignant tumors of the ethmoid and other paranasal sinuses. Principles and results].
Ann Otolaryngol Chir Cervicofac. 1991;108(5):292-7.
8
Subcranial craniofacial resection for advanced sinonasal malignant tumours involving the anterior skull base.
J Laryngol Otol. 2016 Aug;130(8):743-8. doi: 10.1017/S0022215116008318. Epub 2016 Jul 4.
9
Ethmoid adenocarcinoma--from craniofacial to endoscopic resections: a single-institution experience over 25 years.筛窦腺癌——从颅面外科到内镜切除:25 年单机构经验。
Otolaryngol Head Neck Surg. 2011 Aug;145(2):330-7. doi: 10.1177/0194599811403873. Epub 2011 Apr 22.
10
[Adenocarcinoma of the ethmoid sinus in woodworkers. Retrospective study of 25 cases].[木工筛窦腺癌。25例回顾性研究]
Neurochirurgie. 1997;43(2):111-7.

引用本文的文献

1
Trans-Frontal Five-Fluorouracil (TraFFF): a novel technique for the application of adjuvant topical chemotherapeutic agents in sinonasal adenocarcinoma.经额部五氟尿嘧啶(TraFFF):一种在鼻窦腺癌中应用辅助局部化疗药物的新技术。
BMJ Case Rep. 2018 Oct 24;2018:bcr-2018-226234. doi: 10.1136/bcr-2018-226234.
2
Treatment Outcomes of Locally Advanced Squamous Cell Carcinoma of the Ethmoid Sinus Treated with Anterior Craniofacial Resection or Chemoradiotherapy.采用前颅面切除术或放化疗治疗的筛窦局部晚期鳞状细胞癌的治疗结果
Case Rep Oncol. 2017 Apr 18;10(1):339-349. doi: 10.1159/000470834. eCollection 2017 Jan-Apr.
3
Craniofacial Resection for Sinonasal Malignant Tumors: Statistical Analysis of Surgical Outcome over 17 Years at a Single Institution.
鼻窦恶性肿瘤的颅面切除术:单一机构17年手术结果的统计分析
Skull Base. 2011 Jul;21(4):243-8. doi: 10.1055/s-0031-1280686.